CN102174476A - 预防鸭病毒性肝炎的灭活疫苗及其制备方法 - Google Patents
预防鸭病毒性肝炎的灭活疫苗及其制备方法 Download PDFInfo
- Publication number
- CN102174476A CN102174476A CN 201010611929 CN201010611929A CN102174476A CN 102174476 A CN102174476 A CN 102174476A CN 201010611929 CN201010611929 CN 201010611929 CN 201010611929 A CN201010611929 A CN 201010611929A CN 102174476 A CN102174476 A CN 102174476A
- Authority
- CN
- China
- Prior art keywords
- dhav
- duck
- vaccine
- virus
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000272525 Anas platyrhynchos Species 0.000 title claims abstract description 129
- 206010019799 Hepatitis viral Diseases 0.000 title claims abstract description 69
- 238000002360 preparation method Methods 0.000 title claims abstract description 50
- 229940031551 inactivated vaccine Drugs 0.000 title abstract description 10
- 241000700605 Viruses Species 0.000 claims abstract description 33
- 241001651352 Avihepatovirus A Species 0.000 claims abstract description 21
- 208000006454 hepatitis Diseases 0.000 claims abstract description 7
- 231100000283 hepatitis Toxicity 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims description 66
- 230000003612 virological effect Effects 0.000 claims description 51
- 229960002520 hepatitis vaccine Drugs 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 35
- 239000006228 supernatant Substances 0.000 claims description 35
- 230000009849 deactivation Effects 0.000 claims description 33
- 238000004945 emulsification Methods 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 7
- 229960005486 vaccine Drugs 0.000 abstract description 86
- 229940030156 cell vaccine Drugs 0.000 abstract description 19
- 230000002265 prevention Effects 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000005847 immunogenicity Effects 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000003306 harvesting Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 101
- 238000010254 subcutaneous injection Methods 0.000 description 55
- 239000007929 subcutaneous injection Substances 0.000 description 55
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 34
- 231100000614 poison Toxicity 0.000 description 29
- 239000002574 poison Substances 0.000 description 29
- 238000011081 inoculation Methods 0.000 description 21
- 230000036039 immunity Effects 0.000 description 17
- 239000003921 oil Substances 0.000 description 16
- 201000001862 viral hepatitis Diseases 0.000 description 15
- 239000012930 cell culture fluid Substances 0.000 description 12
- 238000004321 preservation Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 239000011259 mixed solution Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000003053 immunization Effects 0.000 description 7
- 238000005070 sampling Methods 0.000 description 7
- 241000272522 Anas Species 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 239000006285 cell suspension Substances 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000010257 thawing Methods 0.000 description 6
- 231100000167 toxic agent Toxicity 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 229940124856 vaccine component Drugs 0.000 description 6
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical class [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 230000007170 pathology Effects 0.000 description 5
- 206010067484 Adverse reaction Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229930182555 Penicillin Natural products 0.000 description 4
- 230000006838 adverse reaction Effects 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000001524 infective effect Effects 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 238000010255 intramuscular injection Methods 0.000 description 4
- 239000007927 intramuscular injection Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 229940049954 penicillin Drugs 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 4
- 230000009885 systemic effect Effects 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- 101000623895 Bos taurus Mucin-15 Proteins 0.000 description 3
- 241000204031 Mycoplasma Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 3
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000004500 asepsis Methods 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 210000004691 chief cell of stomach Anatomy 0.000 description 3
- 238000005138 cryopreservation Methods 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000003760 magnetic stirring Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 238000009781 safety test method Methods 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 238000004114 suspension culture Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000041 toxicology testing Toxicity 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000003837 chick embryo Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000003360 nephrocyte Anatomy 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- 230000001018 virulence Effects 0.000 description 2
- 239000005723 virus inoculator Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- UPLPHRJJTCUQAY-WIRWPRASSA-N 2,3-thioepoxy madol Chemical compound C([C@@H]1CC2)[C@@H]3S[C@@H]3C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C)(O)[C@@]2(C)CC1 UPLPHRJJTCUQAY-WIRWPRASSA-N 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 241001651353 Avihepatovirus Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 241001557655 Duck hepatitis A virus 2 Species 0.000 description 1
- 229940124813 GPR153 ligand Drugs 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010076039 Polyproteins Proteins 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000723848 Tobamovirus Species 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000002976 pectoralis muscle Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
病毒稀释度 | 出现CPE的孔数 |
103 | 16/16 |
104 | 16/16 |
105 | 16/16 |
106 | 13/16 |
107 | 7/16 |
108 | 1/16 |
109 | 0/16 |
1010 | 0/16 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010611929XA CN102174476B (zh) | 2010-12-29 | 2010-12-29 | 预防鸭病毒性肝炎的灭活疫苗及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010611929XA CN102174476B (zh) | 2010-12-29 | 2010-12-29 | 预防鸭病毒性肝炎的灭活疫苗及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102174476A true CN102174476A (zh) | 2011-09-07 |
CN102174476B CN102174476B (zh) | 2012-11-21 |
Family
ID=44517734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010611929XA Active CN102174476B (zh) | 2010-12-29 | 2010-12-29 | 预防鸭病毒性肝炎的灭活疫苗及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102174476B (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102827275A (zh) * | 2012-09-12 | 2012-12-19 | 青岛易邦生物工程有限公司 | 鸭病毒性肝炎二价精制卵黄抗体的制备方法 |
CN102827950A (zh) * | 2012-08-23 | 2012-12-19 | 西南民族大学 | 一种快速定量检测基因c型鸭甲型肝炎病毒的荧光pcr试剂盒 |
CN102827951A (zh) * | 2012-08-23 | 2012-12-19 | 西南民族大学 | 一种基因c型鸭甲型肝炎病毒定性和定量检测方法 |
CN102895660A (zh) * | 2012-10-25 | 2013-01-30 | 中国兽医药品监察所 | 一种鸭病毒性肝炎二价灭活疫苗 |
CN103013931A (zh) * | 2012-12-21 | 2013-04-03 | 哈药集团生物疫苗有限公司 | 一种鸭甲肝病毒js株及其在鸭病毒性肝炎防治中的应用 |
CN103059131A (zh) * | 2012-11-27 | 2013-04-24 | 天津市中升挑战生物工程有限公司 | 防治ⅰ型和ⅲ型鸭病毒性肝炎的二价蛋黄抗体的制备方法 |
CN103865884A (zh) * | 2012-12-11 | 2014-06-18 | 普莱柯生物工程股份有限公司 | 鸭病毒性肝炎二价蛋黄抗体及其制备方法和应用 |
CN104531625A (zh) * | 2014-12-26 | 2015-04-22 | 中国科学院微生物研究所 | 一种鸭病毒性肝炎的灭活疫苗及其制备方法与应用 |
CN104726415A (zh) * | 2015-01-07 | 2015-06-24 | 南京天邦生物科技有限公司 | 一种鸡胚分离培养血清3型鸭甲型肝炎病毒的方法 |
CN104726414A (zh) * | 2015-01-07 | 2015-06-24 | 南京天邦生物科技有限公司 | 血清3型鸭甲型肝炎病毒活疫苗及其制备方法 |
CN106177938A (zh) * | 2016-08-30 | 2016-12-07 | 哈药集团生物疫苗有限公司 | 鸭病毒性肝炎二价灭活疫苗及其制备方法 |
CN108992674A (zh) * | 2018-07-13 | 2018-12-14 | 广东永顺生物制药股份有限公司 | 一种耐热保护剂及其应用 |
CN112375747A (zh) * | 2020-11-18 | 2021-02-19 | 辽宁益康生物股份有限公司 | 一种鸭病毒性肝炎病毒疫苗株、疫苗及疫苗制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101612397A (zh) * | 2009-07-17 | 2009-12-30 | 齐鲁动物保健品有限公司 | 一种鸭病毒性肝炎灭活疫苗及其制备方法 |
-
2010
- 2010-12-29 CN CN201010611929XA patent/CN102174476B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101612397A (zh) * | 2009-07-17 | 2009-12-30 | 齐鲁动物保健品有限公司 | 一种鸭病毒性肝炎灭活疫苗及其制备方法 |
Non-Patent Citations (3)
Title |
---|
《上海畜牧兽医通讯》 20001231 胡建华 等 "鸭病毒性肝炎油佐剂疫苗的研制" 第16-17页 1-10 , 第6期 * |
《中国畜禽种业》 20091231 温纳相 等 "Ⅰ型鸭病毒性肝炎弱毒疫苗对比试验" 第133页 1-10 , 第8期 * |
《家禽科学》 20080331 冯涛 等 "Ⅰ型鸭病毒性肝炎弱毒疫苗的研制" 第39-40页 1-10 , 第3期 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102827950A (zh) * | 2012-08-23 | 2012-12-19 | 西南民族大学 | 一种快速定量检测基因c型鸭甲型肝炎病毒的荧光pcr试剂盒 |
CN102827951A (zh) * | 2012-08-23 | 2012-12-19 | 西南民族大学 | 一种基因c型鸭甲型肝炎病毒定性和定量检测方法 |
CN102827275A (zh) * | 2012-09-12 | 2012-12-19 | 青岛易邦生物工程有限公司 | 鸭病毒性肝炎二价精制卵黄抗体的制备方法 |
CN102895660A (zh) * | 2012-10-25 | 2013-01-30 | 中国兽医药品监察所 | 一种鸭病毒性肝炎二价灭活疫苗 |
CN103059131A (zh) * | 2012-11-27 | 2013-04-24 | 天津市中升挑战生物工程有限公司 | 防治ⅰ型和ⅲ型鸭病毒性肝炎的二价蛋黄抗体的制备方法 |
CN106854647A (zh) * | 2012-12-11 | 2017-06-16 | 普莱柯生物工程股份有限公司 | 鸭病毒性肝炎二价蛋黄抗体及其制备方法和应用 |
CN103865884A (zh) * | 2012-12-11 | 2014-06-18 | 普莱柯生物工程股份有限公司 | 鸭病毒性肝炎二价蛋黄抗体及其制备方法和应用 |
CN106854647B (zh) * | 2012-12-11 | 2021-01-15 | 普莱柯生物工程股份有限公司 | 鸭病毒性肝炎二价蛋黄抗体及其制备方法和应用 |
CN103013931A (zh) * | 2012-12-21 | 2013-04-03 | 哈药集团生物疫苗有限公司 | 一种鸭甲肝病毒js株及其在鸭病毒性肝炎防治中的应用 |
CN104531625A (zh) * | 2014-12-26 | 2015-04-22 | 中国科学院微生物研究所 | 一种鸭病毒性肝炎的灭活疫苗及其制备方法与应用 |
CN104726415A (zh) * | 2015-01-07 | 2015-06-24 | 南京天邦生物科技有限公司 | 一种鸡胚分离培养血清3型鸭甲型肝炎病毒的方法 |
CN104726414A (zh) * | 2015-01-07 | 2015-06-24 | 南京天邦生物科技有限公司 | 血清3型鸭甲型肝炎病毒活疫苗及其制备方法 |
CN106177938A (zh) * | 2016-08-30 | 2016-12-07 | 哈药集团生物疫苗有限公司 | 鸭病毒性肝炎二价灭活疫苗及其制备方法 |
CN108992674A (zh) * | 2018-07-13 | 2018-12-14 | 广东永顺生物制药股份有限公司 | 一种耐热保护剂及其应用 |
CN108992674B (zh) * | 2018-07-13 | 2023-11-10 | 广东永顺生物制药股份有限公司 | 一种耐热保护剂及其应用 |
CN112375747A (zh) * | 2020-11-18 | 2021-02-19 | 辽宁益康生物股份有限公司 | 一种鸭病毒性肝炎病毒疫苗株、疫苗及疫苗制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102174476B (zh) | 2012-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102174476B (zh) | 预防鸭病毒性肝炎的灭活疫苗及其制备方法 | |
CN101948809B (zh) | 预防鸭病毒性肝炎的灭活疫苗及其制备方法 | |
CN104922663B (zh) | 一种鸡新城疫和h9亚型禽流感二联疫苗 | |
CN102492661B (zh) | 防治新型鸭呼肠孤病毒病免疫制剂的制备方法及应用 | |
CN104498441B (zh) | 鸭甲肝病毒iii型弱毒株及由其制备的活疫苗和应用 | |
CN104946600B (zh) | 一种h9亚型禽流感病毒株 | |
CN103305474A (zh) | 猪伪狂犬病毒毒株及其灭活疫苗和应用 | |
CN102086447A (zh) | 鸭病毒性肝炎毒株及灭活疫苗 | |
CN108794627A (zh) | 一种鸭呼肠孤病毒精制卵黄抗体的制备方法 | |
CN104587460B (zh) | 水貂病毒性肠炎、犬瘟热二联活疫苗及其制备方法和应用 | |
CN105949307B (zh) | 一种用于防治番鸭源小鹅瘟的卵黄抗体 | |
CN101612397A (zh) | 一种鸭病毒性肝炎灭活疫苗及其制备方法 | |
CN105031638A (zh) | 一种鸡新城疫、禽流感和传染性法氏囊三联灭活疫苗 | |
CN103143008B (zh) | 一种鸭坦布苏病毒活疫苗及其制备方法 | |
CN103013931B (zh) | 一种鸭甲肝病毒js株及其在鸭病毒性肝炎防治中的应用 | |
CN109207436A (zh) | 一株i群4型禽腺病毒毒株及其应用 | |
CN105274064B (zh) | 一种鸭坦布苏病毒弱毒疫苗株及其应用 | |
CN104087559B (zh) | 一种传染性法氏囊病毒、灭活疫苗及其制备方法 | |
CN105154410B (zh) | 一种鸭细小病毒毒株及其活疫苗 | |
CN101745106A (zh) | 一种猪细小病毒病活疫苗及其制备方法 | |
CN105920596B (zh) | 一种番鸭细小病毒病、小鹅瘟二联疫苗 | |
CN104130981A (zh) | 鸡传染性支气管炎病毒疫苗株及其在制备灭活疫苗中的应用 | |
CN102166355B (zh) | 一种用于预防鸡疾病的四联灭活疫苗 | |
CN104069489B (zh) | 鸡新城疫和传染性法氏囊二联灭活疫苗及其制备方法 | |
CN101130075A (zh) | 口蹄疫O、A、Asia-1型三价灭活疫苗 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: MICROBIOLOGY INST., CHINESE ACADEMY OF SCIENCES Effective date: 20120509 Owner name: BEIJING DABEINONG TECHNOLOGY GROUP CO., LTD. Free format text: FORMER OWNER: MICROBIOLOGY INST., CHINESE ACADEMY OF SCIENCES Effective date: 20120509 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhao Yarong Inventor after: Liu Wenjun Inventor after: Wang Guihua Inventor after: Li Jing Inventor after: Mou Wei Inventor before: Liu Wenjun Inventor before: Zhou Yuancheng Inventor before: Li Jing Inventor before: Bi Yuhai Inventor before: Sun Lei |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100101 CHAOYANG, BEIJING TO: 100097 HAIDIAN, BEIJING Free format text: CORRECT: INVENTOR; FROM: LIU WENJUN ZHOU YUANCHENG LI JING BI YUHAI SUN LEI TO: ZHAO YARONG LIU WENJUN WANG GUIHUA LI JING MOU WEI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120509 Address after: 100097, No. 9 Shuguang Road, Haidian District, Beijing Applicant after: Beijing Dabeinong Technology Group Co., Ltd. Co-applicant after: Institute of Microbiology, Chinese Academy of Sciences Address before: 100101 Institute of Microbiology, Chinese Academy of Sciences, No. 1, West Beichen Road, Chaoyang District, Beijing, A315, Applicant before: Institute of Microbiology, Chinese Academy of Sciences |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200714 Address after: 211102, 999 Ting Dong Road, Jiangning economic and Technological Development Zone, Nanjing, Jiangsu Co-patentee after: INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES Patentee after: Zhaofenghua Biotechnology (Nanjing) Co., Ltd Address before: 100097, No. 9 Shuguang Road, Haidian District, Beijing Co-patentee before: INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES Patentee before: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right |